Quality of medical management in coronary artery disease

Owayed Al Shammeri1, Randall S Stafford, Ahlam Alzenaidi

  • 1Owayed Al-Shammeri, MD, Department of Medicine, Qassim University,, PO Box 6655, Buraidah 51452, Saudi Arabia, T: +966 53 272 1010,, F: +966 11 490 4444, owayed.alshammeri@qumed.edu.sa.

Insights

Optimal medical therapy (OMT) was achieved in only 10.4% of coronary artery disease (CAD) patients. This low rate highlights a critical gap in care, potentially increasing preventable mortality and healthcare costs for high-risk individuals.

Area of Science:

  • Cardiology
  • Public Health
  • Evidence-Based Medicine

Background:

  • Coronary artery disease (CAD) patients face a high risk of recurrent adverse cardiac events.
  • Optimal Medical Therapy (OMT) is guideline-recommended to mitigate these risks.
  • A significant gap exists between recommended OMT and actual clinical practice.

Purpose of the Study:

  • To estimate the rate of achieving Optimal Medical Therapy (OMT) in coronary artery disease (CAD) patients.
  • To identify the adherence rates to specific OMT components in the study population.

Main Methods:

  • An observational study was conducted with 207 consecutive CAD patients.
  • Data were collected via in-person interviews, medical records, and an electronic patient database.
  • Participants were adults (over 18) with documented CAD.

Main Results:

  • Only 10.4% of CAD patients achieved OMT.
  • High adherence rates were observed for blood pressure targets (systolic 76.5%, diastolic 88%) and LDL levels (68%).
  • Medication adherence was high (91%), but only 24% of diabetic patients met the target HbA1c.

Conclusions:

  • Poor achievement of OMT in CAD patients contributes to preventable mortality, morbidity, and increased healthcare costs.
  • The study underscores the need for targeted strategies to improve OMT adherence in this high-risk population.
  • Addressing these shortcomings is crucial for reducing adverse outcomes and healthcare expenditure.
Abstract

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
441
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
490
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
423
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
602
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
530
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
695